UNSPSC 51112201: Bleomycin/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AN200. This VA Drug Class (AN200) classifies this compound as belonging to the group ANTINEOPLASTIC ANTIBIOTICS.

UNSPSC 51112201 Bleomycin/sodium chloride is a Commodity code covering a chemotherapy agent supplied as an injectable pharmaceutical product. State and local governments procure this drug primarily through health departments, public health agencies, correctional health programs, and county and municipal hospital systems to support oncology treatment in public healthcare settings. The drug is typically sourced through state pharmaceutical contracts, group purchasing organization (GPO) agreements, or direct procurement by health systems; quantities and frequency depend on patient census and treatment protocols within each jurisdiction's healthcare delivery infrastructure.

The source material contains no recent state and local contract opportunities tagged to this code. Without posted RFPs, RFQs, IBFs, or ITBs in the opportunity record, no geographic concentration, issuing-body pattern, or representative solicitation activity can be characterized. Procurement of this drug—when it occurs—likely flows through standing pharmaceutical supply agreements and GPO frameworks rather than through individual competitive solicitations visible in public notice systems.